The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO).

Polkowska-Pruszynska, Beata; Gerkowicz, Agnieszka; Rawicz-Pruszynski, Karol; Krasowska, Dorota

Polkowska-Pruszynska, Beata; Gerkowicz, Agnieszka; Rawicz-Pruszynski, Karol; Krasowska, Dorota.

Afiliación

Polkowska-Pruszynska B; Chair and Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, Staszica 16, 20-400 Lublin, Poland.
Gerkowicz A; Chair and Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, Staszica 16, 20-400 Lublin, Poland.
Rawicz-Pruszynski K; Department of Surgical Oncology, Medical University of Lublin, Radziwillowska 13, 20-080 Lublin, Poland.
Krasowska D; Chair and Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, Staszica 16, 20-400 Lublin, Poland.

Diagnostics (Basel) ; 10(8)2020 Aug 13.

Article en En | MEDLINE | ID: mdl-32823752

Palabras clave

SIBO; calprotectin; small intestinal bacterial overgrowth; systemic sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Diagnostics (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google